| DuoResp Spiromax (budesonide/formoterol) / Teva |
2021-003951-41: A Study to Test if Using the BF Digihaler System is Effective in Getting Better Control of Asthma in Adult Patients Compared to Usual Care |
|
|
| Not yet recruiting | 4 | 500 | Europe | Budesonide/Formoterol Digihaler Digital System, ICS/LABA combinations, NA, Inhalation powder, Inhalation solution, ICS/LABA combinations | Teva Branded Pharmaceutical Products R&D, Inc., Teva Branded Pharmaceutical | Asthma, Asthma, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
2014-001563-12: Efficacy of Symptom-driven treatment with inhaled budesonide/formoterol versus fixed dose fluticasone/salmeterol in COPD Effectiviteit van \'symptoom-gestuurde behandeling met het middel Spiromax® budesonide/formoterol versus een vaste dosering Diskus® fluticasone/salmeterol in COPD. |
|
|
| Ongoing | 3 | 260 | Europe | Seretide, DuoResp Spiromax 160 micrograms / 4.5 micrograms inhalation powder, Seretide, DuoResp Spiromax 160 micrograms / 4.5 micrograms inhalation powder, Seretide | University Medical Center Groningen, TEVA pharma | Chronic obstructive pulmonary disease (COPD) Chronisch obstructieve longziekte (COPD) | | | | |
2021-006681-21: Care path consisting of a systematic assessment of asthma patients using digital home monitoring resulting in a patient-centred treatment Zorgpad bestaande uit een systematische beoordeling van astma patiënten met behulp van digitale thuismonitoring wat resulteert in een patiëntgerichte behandeling |
|
|
| Not yet recruiting | 3 | 138 | Europe | Budesonide/formoterol (BF) Digihaler Digital System (DS), Inhalation powder, BF Spiromax | Franciscus Gasthuis & Vlietland, Teva Pharmaceuticals, DSW Transformatiegelden | Asthma Astma, Asthma: alternating airway narrowing and - inflammation Astma: wisselende luchtwegvernauwing en -ontsteking, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
| Recruiting | 3 | 138 | Europe | Budesonide/Formoterol fumarate dihydrate, Budesonide Formoterol (BF) Digihaler Digital System (DS) | Franciscus Gasthuis, Teva Pharmaceuticals USA | Asthma | 01/25 | 06/25 | | |